MAPK3 and hepatocellular carcinoma: The authors then measured the level of DUSP9, ERK1/2 and phospho-ERK1/2 in eight HCC samples and found, as previously reported [79], that DUSP9 was decreased in HCC, and that ERK1/2 and phospho-ERK1/2 were increased in the same samples.